Inventor · disambiguated record
Philip Sheridan
Also filed as: SHERIDAN PHILIP · SHERIDAN PHILIP J · SHERIDAN PHILIP L · SHERIDAN PHILIP LEE
3 granted patents·10 pending applications·53 citations·filing 1990–2011
72Inventor score
Top patents by PatentIndex Score
13 records- 0183US6410316B1Methods for producing a vector producing cell line utilizing a high multiplicity of transductionCHIRON CORP·Filed 2000·Granted Jun 25, 2002·23 cites·15 claims
- 0277US9683985B2Methods for assessing and identifying or evolving conditionally active therapeutic proteinsKODANDAPANI LALITHA·Filed 2011·Granted Jun 20, 2017·8 cites·32 claims
- 0357US2006134103A1Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligandsHAWLEY STEPHEN B·Filed 2005·Application pending·0 cites
- 0450US2003161809A1Compositions and methods for the transport of biologically active agents across cellular barriersFiled 2001·Application pending·0 cites
- 0549US4998842AOvercenter collet space station truss fastenerNASA·Filed 1990·Granted Mar 12, 1991·22 cites·18 claims
- 0649US2003166160A1Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligandsFiled 2001·Application pending·0 cites
- 0749US2002068354A1Feline immunodeficiency virus gene therapy vectorsCHIRON CORP·Filed 2001·Application pending·0 cites
- 0848US2003104611A1Feline immunodeficiency virus gene therapy vectorsFiled 2001·Application pending·0 cites
- 0947US2006099150A1Compositions and methods for the transport of biologically active agents across cellular barriersHOUSTON L L·Filed 2005·Application pending·0 cites
- 1043US2004219542A1Compositions and methods for identifying, characterizing, optimizing and using ligands to transcytotic moleculesFiled 2002·Application pending·0 cites
- 1142US2004157330A1Compositions and methods for targeted biological delivery of molecular carriersARIZEKE PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1234US2007007371A1Under vehicle spray deviceMUTZ ROBERT·Filed 2006·Application pending·0 cites
- 1328US2002048805A1Feline immunodeficiency virus gene therapy vectorsFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →